BRIEF published on 04/29/2026 at 13:05, 6 days 11 hours ago Cheplapharm prévoit une croissance de son chiffre d'affaires en 2025 Croissance Des Revenus Marge D'EBITDA Stabilité Financière Industrie Pharmaceutique CHEPLAPHARM
BRIEF published on 04/29/2026 at 13:05, 6 days 11 hours ago Cheplapharm Sees Revenue Growth in 2025 Pharmaceutical Industry Revenue Growth EBITDA Margin Financial Stability CHEPLAPHARM
PRESS RELEASE published on 04/29/2026 at 13:00, 6 days 12 hours ago CHEPLAPHARM reports Revenue Growth in the 2025 Financial Year CHEPLAPHARM reports 8.1% revenue growth reaching €1.66 billion in FY2025. EBITDA at €642.8 million with a 38.8% margin. Employee count up 2% to 799 Financial Results EBITDA Revenue Growth CHEPLAPHARM Employee Count
BRIEF published on 02/02/2026 at 15:41, 3 months 3 days ago CHEPLAPHARM's Successful €950m Bond Issuance Refinancing Bond Issuance Financial Strategy Investor Demand CHEPLAPHARM
BRIEF published on 02/02/2026 at 15:41, 3 months 3 days ago L'émission obligataire de 950 millions d'euros de CHEPLAPHARM est un succès Stratégie Financière Emission D'obligations Refinancement Demande Des Investisseurs CHEPLAPHARM
PRESS RELEASE published on 02/02/2026 at 15:36, 3 months 3 days ago Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed CHEPLAPHARM successfully refinances with new 6.750% bond oversubscribed multiple times, enhancing financial flexibility and maturity profile Refinancing Oversubscribed Financial Flexibility CHEPLAPHARM 6.750% Bond
BRIEF published on 08/27/2025 at 13:34, 8 months 9 days ago CHEPLAPHARM Reports Stable Growth in the First Half of 2025 Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
BRIEF published on 08/27/2025 at 13:34, 8 months 9 days ago CHEPLAPHARM annonce une croissance stable au premier semestre 2025 Croissance Des Revenus Industrie Pharmaceutique CHEPLAPHARM Programme De Transformation Expansion Des Employés
PRESS RELEASE published on 08/27/2025 at 13:29, 8 months 9 days ago CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024 Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG
BRIEF published on 06/26/2025 at 10:36, 10 months 9 days ago L'obligation de 750 millions d'euros de CHEPLAPHARM connaît une forte demande et un prix attractif Obligations Confiance Des Investisseurs Médicaments Flexibilité Financière CHEPLAPHARM
Published on 05/06/2026 at 00:20, 42 minutes ago Hillcrest Energy Technologies Announces Adoption of Semi-Annual Reporting
Published on 05/06/2026 at 00:00, 1 hour 2 minutes ago Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
Published on 05/05/2026 at 23:00, 2 hours 2 minutes ago Viemed Healthcare Announces First Quarter 2026 Financial Results
Published on 05/05/2026 at 23:00, 2 hours 2 minutes ago Grid Metals Announces TSX Venture Approval for Thompson East Copper/Nickel Project Earn-In Transaction
Published on 05/05/2026 at 22:30, 2 hours 32 minutes ago Totec Resources Adopts Semi-Annual Reporting
Published on 05/06/2026 at 00:05, 57 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 1 hour 57 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 22:07, 2 hours 55 minutes ago Kaufman & Broad SA: MISE EN PAIEMENT DU DIVIDENDE AU TITRE DE L’EXERCICE CLOS LE 30 NOVEMBRE 2025
Published on 05/05/2026 at 22:07, 2 hours 55 minutes ago Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2025
Published on 05/05/2026 at 21:56, 3 hours 6 minutes ago Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM OF 2026, MAY 5
Published on 05/05/2026 at 19:00, 6 hours 2 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 19:00, 6 hours 2 minutes ago Assemblée Générale Mixte des Actionnaires d’Air Liquide du 5 mai 2026
Published on 05/05/2026 at 18:40, 6 hours 22 minutes ago Mise en œuvre du programme de rachat d’actions
Published on 05/05/2026 at 18:03, 6 hours 59 minutes ago Aéroports de Paris SA - Actions et droits de vote au 30 avril 2026
